Aerie Pharma upsizes and prices private sale of $275-million of convertible notes - BioTuesdays
Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update | Business Wire
Aerie Pharmaceuticals - Positive Rhopressa Launch May Mark The Stock Price Peak (NASDAQ:AERI) | Seeking Alpha
Aerie Pharmaceuticals (AERI) Stock Forecast, Price Targets and Analysts Predictions - TipRanks.com
Aerie Pharma Re-Ups In Irvine, CEO Departs - Orange County Business Journal
Aerie to Acquire Dry Eye Disease-Focused Pharma Avizorex
AERIE PHARMACEUTICALS, INC. NPS 2022
Aerie Pharmaceuticals Stock Forecast, Price & News (NASDAQ:AERI)
Aerie Pharmaceuticals Inc - For Investor Use Important Information The information in this presentation does not contain all of the information that a potential investor should review before investing in Aerie shares.
Alcon ups its glaucoma game again with $770M Aerie Pharma acquisition - MedCity News
Aerie Pharma (AERI) Falls on Glaucoma Eye Drop Safety Concerns - TheStreet
Aerie Pharmaceuticals, Inc. Announces Executive Changes
Aerie Pharmaceuticals Inc. Company Profile - The Business Journals
Aerie Pharmaceuticals, Inc. (Aerie Pharmace) Stock Price & News | AERI
Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update | Business Wire
Aerie Pharmaceuticals Inc - For Investor Use Important Information The information in this presentation does not contain all of the information that a potential investor should review before investing in Aerie shares.
AERIE PHARMACEUTICALS, INC. NPS 2022
Aerie Pharma: What To Do After Shares Rocket Higher? (NASDAQ:AERI) | Seeking Alpha
Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results | Business Wire
Aerie Pharmaceuticals Inc - Important Information The information in this presentation does not contain all of the information that a potential investor should review before investing in Aerie shares. The descriptions of
Aerie Pharma rises 14% after Q2 result beat on higher glaucoma franchise sales | Seeking Alpha
Aerie Pharmaceuticals - Positive Rhopressa Launch May Mark The Stock Price Peak (NASDAQ:AERI) | Seeking Alpha
Aerie Pharmaceuticals shares jump on FDA approval of glaucoma drug Rocklatan | NASDAQ:AERI
Aerie Pharmaceuticals - Positive Rhopressa Launch May Mark The Stock Price Peak (NASDAQ:AERI) | Seeking Alpha
Buy Aerie Pharmaceuticals Stock - AERI Stock Price Today & News - Public.com
Aerie Pharmaceuticals (AERI) Stock Price, Quote, News & Analysis - TipRanks.com
